menu
    • menu

    Company profile for X4 Pharmaceuticals

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    X4 is focused on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Our first-in-class, oral, small molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. A number of PIs are attributed to the improper trafficking of immune cells related ...
    X4 is focused on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Our first-in-class, oral, small molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. A number of PIs are attributed to the improper trafficking of immune cells related to the CXCR4 receptor and its ligand CXCL12.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    X4 PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    955 Massachusetts Avenue, 4th Floor Cambridge, MA 02139
    Telephone
    Telephone
    +(857) 529-8300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.x4pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/x4-pharmaceuticals/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    X4 Pharma Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
    X4 Pharma Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)

    15 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/15/3134463/0/en/X4-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    15 Aug 2025
    Share Share
    X4 Pharmaceuticals Closes Upsized $85M Private Placement
    X4 Pharmaceuticals Closes Upsized $85M Private Placement

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132432/0/en/X4-Pharmaceuticals-Announces-Closing-of-Upsized-85-Million-Private-Placement.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    X4 Pharma Secures $60M Equity Financing, Changes Management
    X4 Pharma Secures $60M Equity Financing, Changes Management

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3131563/0/en/X4-Pharmaceuticals-Announces-60-Million-Equity-Financing-with-Concurrent-Changes-in-Management-and-Board-Leadership.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share
    X4 Pharmaceuticals Presents Positive Phase 2 Trial Data at EHA
    X4 Pharmaceuticals Presents Positive Phase 2 Trial Data at EHA

    16 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/16/3099765/0/en/X4-Pharmaceuticals-Presents-Positive-Phase-2-Chronic-Neutropenia-Trial-Data-in-Poster-Presentations-at-the-30th-Annual-Congress-of-the-European-Hematology-Association-EHA.html

    GLOBENEWSWIRE
    16 Jun 2025
    Share Share
    X4 Pharmaceuticals Granted Fast Track for Mavorixafor by FDA
    X4 Pharmaceuticals Granted Fast Track for Mavorixafor by FDA

    10 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/10/3096587/0/en/X4-Pharmaceuticals-Granted-Fast-Track-Designation-for-Mavorixafor-for-the-Treatment-of-Chronic-Neutropenia-by-U-S-FDA.html

    GLOBENEWSWIRE
    10 Jun 2025
    Share Share
    X4 Pharma Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
    X4 Pharma Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3092328/0/en/X4-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search